Evidence map›Paper›PMID 40853407›Full record

ArticleNatural products and bioprospecting2025

(+)-/(-)-Ormohenins A and B, two pairs of ormosanine-type enantiomers and their derivatives with neuroprotective activity from Ormosia henryi Prain.

Ming Cheng, Xian-Si Zeng, Zhao-Yun Yin, Xiao-Yan Xie, Jia-Wen Zhu, Jian-Feng Wang, Ying-Kun Sheng, Jin-Biao Xu

Abstract read
In one paragraph

Article in Natural products and bioprospecting, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ming Cheng *Xingzhi College, Zhejiang Normal University, Jinhua, 321004, China.
Xian-Si Zeng *College of Medicine, Jiaxing University, Jiaxing, 314001, China.
Zhao-Yun Yin *College of Medicine, Jiaxing University, Jiaxing, 314001, China.
Xiao-Yan XieCollege of Medicine, Jiaxing University, Jiaxing, 314001, China.
Jia-Wen ZhuCollege of Medicine, Jiaxing University, Jiaxing, 314001, China.
Jian-Feng WangXingzhi College, Zhejiang Normal University, Jinhua, 321004, China.
Ying-Kun ShengXingzhi College, Zhejiang Normal University, Jinhua, 321004, China.
Jin-Biao XuXingzhi College, Zhejiang Normal University, Jinhua, 321004, China. xujinbiao2015@126.com.ORCID http://orcid.org/0000-0003-3251-5044

Funding

National Natural Science Foundation of China 82003612Startup Funding from Xingzhi College of Zhejiang Normal University ZC302925002
6 · The paper itself

Abstract

Two pairs of undescribed alkaloid enantiomers, (+)-/(-)-ormohenins A (1) and B (2), were isolated from the seeds of Ormosia henryi Prain, along with four undescribed alkaloids (3, 4, 7 and 8) and seven known ones (5, 6, 9-13). Compounds 1-6 belong to the ormosanine-type alkaloids, compounds 7, 9, and 11 are of the lupinine-type, compounds 8 and 10 are classified as anagyrine-type alkaloids, 12 and 13 are cytisine-type alkaloids. The chemical structures of 1-13 were elucidated through comprehensive NMR and MS data analyses. Furthermore, the racemates (±)-1 and (±)-2 were successfully resolved into their respective optically pure enantiomers using a chiral HPLC system. The absolute configurations of compounds 1-3 were determined using single-crystal X-ray diffraction and corroborated by DFT calculations of specific rotations. The absolute configurations of 4, 7, and 8 were assigned by the experimental electronic circular dichroism (ECD) with those predicted using TDDFT calculations. Compound 12 exhibited significant acetylcholinesterase (AChE) inhibitory activity with the IC

Indexed as

AChE inhibitoryNeuroprotective activityOrmosanine-type alkaloidsOrmosia henryiSpecific rotation calculations

Identifiers

PMID40853407
PMCPMC12378240

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.